(Q57681342)

2

0 references

Jann Mortensen

object named as

Jann Mortensen

3

0 references

Andreas Kjær

object named as

Andreas Kjaer

6

0 references

author name string

Ulrik Sloth Kristoffersen

1

0 references

Jan Gerstoft

Clinical Physiology and Functional Imaging

4

0 references

publication date

11 March 2012

0 references

published in

0 references

volume

32

0 references

issue

4

0 references

page(s)

288-295

0 references

cites work

Tobacco use and readiness to quit smoking in low-income HIV-infected persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Increased COPD among HIV-positive compared to HIV-negative veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Respiratory symptoms among HIV-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Prevalence of obstructive lung disease in HIV population: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Effects of smoking and clinical status on lung function in human immunodeficiency virus (HIV)-seropositive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Prevalence of bronchial hyperresponsiveness among HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X

The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2012.01124.X